Title:
FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/011540
Kind Code:
A1
Abstract:
A fused ring compound, a pharmaceutical composition, and an application thereof. Provided is a fused ring compound shown in formula I or a pharmaceutically acceptable salt thereof. The compound has a novel structure and good SOS1 inhibitory activity.
More Like This:
Inventors:
WU DONGDONG (CN)
LI XIN (CN)
XU JIAJING (CN)
XU LINFENG (CN)
WU YUCHUAN (CN)
HU YONGHAN (CN)
LI XIN (CN)
XU JIAJING (CN)
XU LINFENG (CN)
WU YUCHUAN (CN)
HU YONGHAN (CN)
Application Number:
PCT/CN2022/110019
Publication Date:
February 09, 2023
Filing Date:
August 03, 2022
Export Citation:
Assignee:
EVOPOINT BIOSCIENCES CO LTD (CN)
International Classes:
C07D471/04; A61K31/519; A61P35/00; C07D453/02; C07D519/00
Domestic Patent References:
WO2021259972A1 | 2021-12-30 | |||
WO2022017519A1 | 2022-01-27 | |||
WO2022140427A1 | 2022-06-30 | |||
WO2020254451A1 | 2020-12-24 | |||
WO2019122129A1 | 2019-06-27 |
Foreign References:
CN114907341A | 2022-08-16 | |||
CN113200981A | 2021-08-03 | |||
CN114456165A | 2022-05-10 | |||
CN114524810A | 2022-05-24 | |||
CN114539245A | 2022-05-27 | |||
CN114835703A | 2022-08-02 | |||
CN111372932A | 2020-07-03 | |||
CN202110884595A | 2021-08-03 | |||
CN202111063419A | 2021-09-10 | |||
CN202111300099A | 2021-11-04 | |||
CN202111415010A | 2021-11-25 | |||
CN202210068494A | 2022-01-20 |
Other References:
"Pharmacopoeia of The People's Republic of China", 2015, article "4"
RAYMOND C ROWE: "Handbook of Pharmaceutical Excipients", 2009
RAYMOND C ROWE: "Handbook of Pharmaceutical Excipients", 2009
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: